Aveanna Healthcare Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aveanna Healthcare Hldgs (AVAH).

Price Target Range — 9 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

7Buy

3Hold

Consensus RatingNeutral# Analysts11Avg. Consensus PT$13Upside to Avg. PT-2.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	JP Morgan	Benjamin Rossi	PT Raise	Neutral	$8→$15
Aug 28, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$10→$15
Aug 24, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$11→$15
Aug 24, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$10→$16
Aug 14, 2026	UBS	A.J. Rice	PT Raise	Neutral	$8→$13
Aug 14, 2026	Raymond James	John Ransom	PT Raise	Strong Buy	$13→$15
Aug 14, 2026	BMO Capital	Sean Dodge	PT Raise	Outperform	$10→$14
Jul 14, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$9→$11
Jul 9, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$9→$10
Jun 3, 2026	RBC Capital	Ben Hendrix	Upgrade	Sector Perform→Outperform	$10
May 20, 2026	Truist Securities	David Macdonald	PT Raise	Hold	$8→$9
May 18, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$10→$9
May 15, 2026	Stephens & Co.	Scott Fidel	Upgrade	Equal-Weight→Overweight	$10→$11
May 15, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$9→$10
Apr 13, 2026	Truist Securities	David Macdonald	PT Cut	Hold	$9→$8
Mar 25, 2026	Barclays	Andrew Mok	PT Cut	Overweight	$11→$10
Mar 23, 2026	RBC Capital	Ben Hendrix	PT Cut	Sector Perform	$11→$9
Mar 20, 2026	BMO Capital	Sean Dodge	PT Cut	Outperform	$11→$10
Mar 20, 2026	Truist Securities	David Macdonald	PT Cut	Hold	$10→$9
Jan 16, 2026	Barclays	Andrew Mok	PT Raise	Overweight	$9→$11

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

JP Morgan analyst Benjamin Rossi maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $15.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $11 to $15.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $16.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises the price target from $8 to $13.

Benzinga Newsdesk

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and raises the price target from $13 to $15.

Benzinga Newsdesk

Aveanna Healthcare Holdings Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Aveanna Healthcare Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

People Also Watch

People Also Watch

Aveanna Healthcare Holdings Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Aveanna Healthcare Hldgs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

PROBarclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

PROTruist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRORBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

PROUBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

PRORaymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15

PRO
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16

PRO
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $13

PRO
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15